HELIX BIOPHARMA (Germany) Market Value

HBP Stock  EUR 1.15  0.00  0.00%   
HELIX BIOPHARMA's market value is the price at which a share of HELIX BIOPHARMA trades on a public exchange. It measures the collective expectations of HELIX BIOPHARMA investors about its performance. HELIX BIOPHARMA is selling for under 1.15 as of the 27th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.15.
With this module, you can estimate the performance of a buy and hold strategy of HELIX BIOPHARMA and determine expected loss or profit from investing in HELIX BIOPHARMA over a given investment horizon. Check out HELIX BIOPHARMA Correlation, HELIX BIOPHARMA Volatility and HELIX BIOPHARMA Alpha and Beta module to complement your research on HELIX BIOPHARMA.
Symbol

Please note, there is a significant difference between HELIX BIOPHARMA's value and its price as these two are different measures arrived at by different means. Investors typically determine if HELIX BIOPHARMA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HELIX BIOPHARMA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

HELIX BIOPHARMA 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HELIX BIOPHARMA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HELIX BIOPHARMA.
0.00
12/08/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/27/2024
0.00
If you would invest  0.00  in HELIX BIOPHARMA on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding HELIX BIOPHARMA or generate 0.0% return on investment in HELIX BIOPHARMA over 720 days. HELIX BIOPHARMA is related to or competes with GEELY AUTOMOBILE, 24SEVENOFFICE GROUP, Cars, Corporate Office, Waste Management, and Perdoceo Education. More

HELIX BIOPHARMA Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HELIX BIOPHARMA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HELIX BIOPHARMA upside and downside potential and time the market with a certain degree of confidence.

HELIX BIOPHARMA Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for HELIX BIOPHARMA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HELIX BIOPHARMA's standard deviation. In reality, there are many statistical measures that can use HELIX BIOPHARMA historical prices to predict the future HELIX BIOPHARMA's volatility.
Hype
Prediction
LowEstimatedHigh
1.151.151.15
Details
Intrinsic
Valuation
LowRealHigh
1.151.151.15
Details
Naive
Forecast
LowNextHigh
1.151.151.15
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.151.151.15
Details

HELIX BIOPHARMA Backtested Returns

We have found three technical indicators for HELIX BIOPHARMA, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and HELIX BIOPHARMA are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

HELIX BIOPHARMA has no correlation between past and present. Overlapping area represents the amount of predictability between HELIX BIOPHARMA time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HELIX BIOPHARMA price movement. The serial correlation of 0.0 indicates that just 0.0% of current HELIX BIOPHARMA price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.18

HELIX BIOPHARMA lagged returns against current returns

Autocorrelation, which is HELIX BIOPHARMA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting HELIX BIOPHARMA's stock expected returns. We can calculate the autocorrelation of HELIX BIOPHARMA returns to help us make a trade decision. For example, suppose you find that HELIX BIOPHARMA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

HELIX BIOPHARMA regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If HELIX BIOPHARMA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if HELIX BIOPHARMA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in HELIX BIOPHARMA stock over time.
   Current vs Lagged Prices   
       Timeline  

HELIX BIOPHARMA Lagged Returns

When evaluating HELIX BIOPHARMA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of HELIX BIOPHARMA stock have on its future price. HELIX BIOPHARMA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, HELIX BIOPHARMA autocorrelation shows the relationship between HELIX BIOPHARMA stock current value and its past values and can show if there is a momentum factor associated with investing in HELIX BIOPHARMA.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for HELIX Stock Analysis

When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.